These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 28664662)

  • 21. Multiple kernel learning with random effects for predicting longitudinal outcomes and data integration.
    Chen T; Zeng D; Wang Y
    Biometrics; 2015 Dec; 71(4):918-28. PubMed ID: 26177419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting individual brain functional connectivity using a Bayesian hierarchical model.
    Dai T; Guo Y;
    Neuroimage; 2017 Feb; 147():772-787. PubMed ID: 27915121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.
    Steenland K; Zhao L; John SE; Goldstein FC; Levey A; Alvaro A;
    J Alzheimers Dis; 2018; 63(4):1383-1393. PubMed ID: 29843232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative.
    Koppel J; Sunday S; Goldberg TE; Davies P; Christen E; Greenwald BS;
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):698-707. PubMed ID: 23672944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of longitudinal diffusion-weighted images in healthy and pathological aging: An ADNI study.
    Kruggel F; Masaki F; Solodkin A;
    J Neurosci Methods; 2017 Feb; 278():101-115. PubMed ID: 28057473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Mixed-Effects Model with Time Reparametrization for Longitudinal Univariate Manifold-Valued Data.
    Schiratti JB; Allassonnière S; Routier A; Durrleman S
    Inf Process Med Imaging; 2015; 24():564-75. PubMed ID: 26221703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Neuroimaging Hippocampal Markers for Diagnosing Alzheimer's Disease.
    Platero C; Lin L; Tobar MC
    Neuroinformatics; 2019 Jan; 17(1):43-61. PubMed ID: 29785624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint analysis of multivariate interval-censored survival data and a time-dependent covariate.
    Wu D; Li C
    Stat Methods Med Res; 2021 Mar; 30(3):769-784. PubMed ID: 33256555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable selection for joint models of multivariate longitudinal measurements and event time data.
    Chen Y; Wang Y
    Stat Med; 2017 Oct; 36(24):3820-3829. PubMed ID: 28707701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediation Analysis with Multiple Exposures and Multiple Mediators.
    Zhao Y
    Stat Med; 2024 Nov; 43(25):4887-4898. PubMed ID: 39250913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence analysis for skew-normal semiparametric joint models of multivariate longitudinal and multivariate survival data.
    Tang AM; Tang NS; Zhu H
    Stat Med; 2017 Apr; 36(9):1476-1490. PubMed ID: 28070895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint modeling of recurrent events and a terminal event adjusted for zero inflation and a matched design.
    Xu C; Chinchilli VM; Wang M
    Stat Med; 2018 Aug; 37(18):2771-2786. PubMed ID: 29682772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling longitudinal data with nonparametric multiplicative random effects jointly with survival data.
    Ding J; Wang JL
    Biometrics; 2008 Jun; 64(2):546-56. PubMed ID: 17888040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On longitudinal prediction with time-to-event outcome: Comparison of modeling options.
    Maziarz M; Heagerty P; Cai T; Zheng Y
    Biometrics; 2017 Mar; 73(1):83-93. PubMed ID: 27438160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal latent variable models given incompletely observed biomarkers and covariates.
    Ren C; Shin Y
    Stat Med; 2016 Nov; 35(26):4729-4745. PubMed ID: 27377366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling.
    Venkatraghavan V; Bron EE; Niessen WJ; Klein S;
    Neuroimage; 2019 Feb; 186():518-532. PubMed ID: 30471388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H-likelihood approach for joint modeling of longitudinal outcomes and time-to-event data.
    Ha ID; Noh M; Lee Y
    Biom J; 2017 Nov; 59(6):1122-1143. PubMed ID: 29139605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling the underlying biological processes in Alzheimer's disease using a multivariate competing risk joint model.
    van Oudenhoven FM; Swinkels SHN; Hartmann T; Rizopoulos D
    Stat Med; 2022 Jul; 41(17):3421-3433. PubMed ID: 35582814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.